TMCnet News
Research and Markets: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 - Executive Summary Report for the $16 Billion IndustryDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/sll8mk/u_s_market_for) has announced the addition of the "U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 (Executive Summary)" report to their offering. This executive summary release to the report U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014. According to the Center for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death among Americans as of 2014. Moreover, diagnosed diabetes had an estimated cost of over $245 billion in the U.S. in 2013. The prevalence of the disease led to a market size for diabetes monitoring, treatment and drug delivery of over $16.7 billion. This market will grow in conjunction with the numer of diagnosed diabetics. Some segments will grow faster than others as the demand for modern and more efficient products is increasing faster than the rate of new diabetics. Conversely, reimbursement cuts and declining prices in some segments will affect the market negatively. Scope of report:
Key Topics Covered: 1 Executive Summary 2. Methodology 3. U.S. Diabetes Diagnosis, Treatment And Drug Delivery Market 4. Traditional Blood Glucose Meter Market 5. Blood Glucose Test Strip Market 6. Lancet And Lancing Device Market 7. Continuous Glucose Monitoring Market 8. Insulin Pump Market 9. Modern Insulin Market 10. Insulin Syringe Market 11. Modern Insulin Pen Market 12. Abbreviations Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/sll8mk/u_s_market_for
|
